Paxlovid, Pfizer’s anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration. File | Photo Credit: Reuters Chinese health experts are warning that fake versions of Indian generic medicines are flooding the black market in China as a record surge of COVID-19 cases fuels demand for antivirals, particularly Pfizer’s Paxlovid and … Read more
Beijing: A Chinese healthcare platform has started selling Pfizer‘s oral COVID treatment pill Paxlovid in what appears to be the first retail sale of the drug in the country, as China braces for a surge in COVID patients. The medication sold out just over half an hour after the listing was reported in the media, … Read more
July 27, 2022 – President Joe Biden has tested negative for COVID-19, after testing positive a week ago. Biden, who has been isolating for the past 5 days, has no fever and his symptoms are “steadily improving,” according to his personal doctor, Kevin O’Connor, DO. The president will resume his normal duties and end his … Read more
The companies have received the nod after inking a sub-licensing pact with Medicines Patent Pool (MPP), a UN-based public health organisation working to increase access to life-saving medicines for low- and middle-income countries. Leading drug makers Cadila Pharmaceuticals, Aurobindo Pharma and Torrent Pharmaceuticals on Thursday said they have received a licence to manufacture a generic … Read more
The European Union’s drug regulator on Thursday conditionally approved the use of Pfizer Inc’s antiviral COVID-19 pill for treating adults at risk of severe illness, as the region scrambles to boost its arsenal to fight the Omicron variant. The endorsement by the European Medicines Agency (EMA) allows EU member states to deploy the drug after … Read more
Paxlovid can cut the risk of hospitalisation in vulnerable adults by 89%, a clinical trial suggests. Source link